Loan Type Today Last Week
30 Year Fixed 6.35% 6.51%
15 Year Fixed 5.90% 6.04%
1 Year ARM 5.69% 6.30%
30 Year Fixed Jumbo 7.51% 7.49%
5/1 ARM 5.88% 5.97%
3/1 ARM 5.63% 5.84%
www.crownequityholdings.com | www.ctsproducts.com | www.crowntradingsystems.com | www.crwenews.com | www.crwenewswire.com | www.crwefinance.com | www.tisamall.com | www.crownbeautymall.com | www.medicrown.com
Crown Equity Holdings, Inc., Publicly Traded: (CRWE.OB) | Follow Our Success at Yahoo! Finance: http://finance.yahoo.com/q?s=CRWE.OB
Archive for July, 2008
Mortgag RATES:/CRWE.OB
On July - 31 - 2008
Chairman Alan Greenspan,
On July - 31 - 2008
Companies:Fannie Mae | Freddie Mac
By CNBC.com | 31 Jul 2008 | 03:46 PM ET
Font size:
Former Federal Reserve Chairman Alan Greenspan said the US is “nowhere near the bottom” of the housing slump and is “right on the brink” of a recession.
Alan Greenspan
J. Scott Applewhite / AP
In an exclusive interview on CNBC, Greenspan said the US [...]
YHOO, Yahoo two insider sold 1million shares/CRWE.ob
On July - 31 - 2008
www.crownequityholdings.com | www.ctsproducts.com | www.crowntradingsystems.com | www.crwenews.com | www.crwenewswire.com | www.crwefinance.com | www.tisamall.com | www.crownbeautymall.com | www.medicrown.com
Crown Equity Holdings, Inc., Publicly Traded: (CRWE.OB) | Follow Our Success at Yahoo! Finance: http://finance.yahoo.com/q?s=CRWE.OB
Emulex Corporation,CRWE.OB
On July - 31 - 2008
To ensure delivery to your inbox, please add communications@emulex.com to your address book.
for Emulex Resellers and Partners
August 12 at 10:30am PDT
Improve management efficiency, increase SAN availability and enhance performance with HBAnyware 4.0, Emulex’s Next Generation Connectivity Management Solution. > MORE
Invest an hour discovering Emulex
HBAnyware 4.0 management software and
save days managing your customer’s SAN.
[...]
NVO,Novo-Nordisk is buy…………………….MAD MONEY BY Jim Creamer/crwe.ob
On July - 31 - 2008
on July,7,08 Amylin Pharms: Stanford believes FDA guidelines in Type 2 diabetes positive for AMLN (25.51 ) : Stanford believes the new FDA guidelines in Type 2 diabetes would be a negative for Takeda’s alogliptin and Novo Nordisk’s (NVO) liraglutide, and positive for Amylin’s (AMLN) Byetta and Merck’s (MRK) Januvia. Firm notes AMLN/Lilly’s (LLY) once [...]
